Anticoagulants may prolong lives of prostate cancer patients

02/22/2013 | HealthDay News

Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found that those treated with anticoagulants such as heparin and warfarin lived longer than those who didn't receive the medications. Use of blood thinners was associated with a 39% increase in overall survival. The study looked at patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA